This article has been updated to include comments from DiaSorin management made during a conference call to discuss the deal.

NEW YORK (GenomeWeb) – Italian diagnostics firm DiaSorin has signed an agreement to acquire Focus Diagnostics' immunoassay and molecular diagnostics products business from Quest Diagnostics for $300 million in cash, the companies announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.